NEW YORK (GenomeWeb News) – Luminex today said total second-quarter revenues increased 25 percent as a net loss turned into a profit.
 
Receipts for the three months ended June 30 increased to $13 million from $10.7 million year over year. The company said it generated $5.8 million from the sale of 205 Luminex Systems in the period.
 
R&D costs increased 20 percent to $1.8 million from $1.5 million from the comparable quarter a year ago.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.